Device Trial Radar · NCT02982174
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
Last checked: Nov 20, 2026Latest source record: Jun 8, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
15
Actual
Start
Dec 2016
Primary completion
Dec 2016
Study completion Jan 2017
Sponsor
- Lead sponsor
- Topcon Medical Systems, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 5, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Compare the signal to noise ratio of each device at various retinal layers.
Conditions
- Healthy Eyes
Interventions
3D OCT-1 MaestroDevice
Image acquisition of the posterior surface of the eye
DRI OCT TritonDevice
Image acquisition of the posterior surface of the eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Signal to noise ratio between SD OCT and SS OCTTime frame: 5 minutes
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Topcon Medical Systems Inc.
Oakland, New Jersey
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.